Advisor Group Holdings, Inc. Cytosorbents Corp Transaction History

Advisor Group Holdings, Inc.

$42.1 Billion
Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Cytosorbents Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 163,748 shares of CTSO stock, worth $140,823. This represents 0.0% of its overall portfolio holdings.

Number of Shares

163,748

Previous 122,420 33.76%

Holding current value

$140,823

Previous $110,000 48.18%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$0.89 - $1.3 $36,781 - $53,726	41,328 Added 33.76%	163,748 $163,000
Q3 2024 Nov 13, 2024	BUY	$0.7 - $1.55 $7,000 - $15,500	10,000 Added 8.9%	122,420 $183,000
Q2 2024 Aug 13, 2024	SELL	$0.7 - $1.01 $972 - $1,403	-1,390 Reduced 1.22%	112,420 $78,000
Q1 2024 May 10, 2024	BUY	$0.86 - $1.07 $946 - $1,177	1,100 Added 0.98%	113,810 $108,000
Q4 2023 Feb 12, 2024	SELL	$1.08 - $1.94 $78,377 - $140,789	-72,572 Reduced 39.17%	112,710 $125,000
Q3 2023 Nov 13, 2023	BUY	$1.86 - $4.03 $198,783 - $430,698	106,873 Added 136.3%	185,282 $348,000
Q2 2023 Aug 10, 2023	BUY	$2.37 - $3.65 $362 - $558	153 Added 0.2%	78,409 $281,000
Q1 2023 May 12, 2023	BUY	$1.79 - $4.17 $4,526 - $10,545	2,529 Added 3.34%	78,256 $263,000
Q4 2022 Feb 10, 2023	BUY	$1.03 - $2.03 $988 - $1,948	960 Added 1.28%	75,727 $117,000
Q3 2022 Nov 14, 2022	SELL	$1.2 - $2.46 $1,320 - $2,706	-1,100 Reduced 1.45%	74,767 $101,000
Q2 2022 Aug 10, 2022	BUY	$1.76 - $3.22 $1,640 - $3,001	932 Added 1.24%	75,867 $166,000
Q1 2022 May 04, 2022	SELL	$2.88 - $4.23 $4,674 - $6,865	-1,623 Reduced 2.12%	74,935 $1.54 Million
Q3 2021 Nov 05, 2021	SELL	$7.0 - $9.71 $8,344 - $11,574	-1,192 Reduced 1.53%	76,558 $623,000
Q2 2021 Aug 02, 2021	BUY	$7.55 - $9.42 $31,710 - $39,564	4,200 Added 5.71%	77,750 $588,000
Q1 2021 May 13, 2021	SELL	$8.23 - $11.48 $6,995 - $9,758	-850 Reduced 1.14%	73,550 $639,000
Q4 2020 Feb 10, 2021	BUY	$7.65 - $8.98 $155,983 - $183,102	20,390 Added 37.75%	74,400 $594,000
Q3 2020 Nov 12, 2020	BUY	$7.37 - $11.54 $113,866 - $178,293	15,450 Added 40.07%	54,010 $431,000
Q2 2020 Aug 14, 2020	SELL	$6.28 - $10.59 $34,037 - $57,397	-5,420 Reduced 12.32%	38,560 $382,000
Q1 2020 May 18, 2020	BUY	$3.77 - $7.73 $165,804 - $339,965	43,980 New	43,980 $281,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.2M

Call Options Held

8.1K

Put Options Held

6.9K

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $37.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Cytosorbents Corp Transaction History